씨지인바이츠(주)

{
  "address": "서울 강서구",
  "ceo_name": "이호영, 오수연",
  "certificate": [
    {
      "cert_number": "20001522120888",
      "changes": "",
      "disclosure_date": "2000-12-08",
      "first_cert_date": "2000-12-08",
      "no": "1",
      "type": "기타",
      "valid_period": "2000-12-08 ~ 2002-12-07"
    },
    {
      "cert_number": "021535021201811",
      "changes": "",
      "disclosure_date": "2002-11-20",
      "first_cert_date": "2000-12-08",
      "no": "2",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2002-11-20 ~ 2004-11-19"
    },
    {
      "cert_number": "051135032301126",
      "changes": "",
      "disclosure_date": "2004-11-20",
      "first_cert_date": "2000-12-08",
      "no": "3",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2004-11-20 ~ 2006-11-19"
    },
    {
      "cert_number": "061135032400991",
      "changes": "",
      "disclosure_date": "2006-06-03",
      "first_cert_date": "2000-12-08",
      "no": "4",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2006-06-03 ~ 2008-06-02"
    },
    {
      "cert_number": "20080103478",
      "changes": "",
      "disclosure_date": "2008-05-29",
      "first_cert_date": "2000-12-08",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2008-06-03 ~ 2010-06-02"
    },
    {
      "cert_number": "20100104797",
      "changes": "",
      "disclosure_date": "2010-05-20",
      "first_cert_date": "2000-12-08",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2010-06-03 ~ 2012-06-02"
    },
    {
      "cert_number": "20120106554",
      "changes": "",
      "disclosure_date": "2012-07-17",
      "first_cert_date": "2000-12-08",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2012-06-03 ~ 2014-06-02"
    },
    {
      "cert_number": "20140106706",
      "changes": "",
      "disclosure_date": "2014-06-03",
      "first_cert_date": "2000-12-08",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2014-06-03 ~ 2016-06-02"
    },
    {
      "cert_number": "20160107729",
      "changes": "",
      "disclosure_date": "2016-06-27",
      "first_cert_date": "2000-12-08",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2016-06-03 ~ 2018-06-02"
    },
    {
      "cert_number": "20180106387",
      "changes": "",
      "disclosure_date": "2018-05-28",
      "first_cert_date": "2000-12-08",
      "no": "10",
      "type": "연구개발유형",
      "valid_period": "2018-06-03 ~ 2020-06-02"
    },
    {
      "cert_number": "20200107912",
      "changes": "",
      "disclosure_date": "2020-06-15",
      "first_cert_date": "2000-12-08",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2020-06-03 ~ 2022-06-02"
    },
    {
      "cert_number": "20220811020010",
      "changes": "",
      "disclosure_date": "2022-08-11",
      "first_cert_date": "2000-12-08",
      "no": "12",
      "type": "연구개발유형",
      "valid_period": "2022-06-03 ~ 2025-06-02"
    },
    {
      "cert_number": "20250709020016",
      "changes": "",
      "disclosure_date": "2025-07-09",
      "first_cert_date": "2000-12-08",
      "no": "13",
      "type": "연구개발유형",
      "valid_period": "2025-06-03 ~ 2028-06-02"
    }
  ],
  "company_name": "씨지인바이츠(주)",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 35373243000,
      "cost_of_sales": 4378078000,
      "current_assets": 63101027000,
      "current_liabilities": 37475732000,
      "gross_profit": 1495390000,
      "net_income": -26383313000,
      "net_income_bs": -26995057000,
      "non_current_assets": 211772484000,
      "non_current_liabilities": 51196878000,
      "non_operating_expenses": 11627985000,
      "non_operating_income": 7319274000,
      "operating_profit": -22074602000,
      "revenue": 5873467000,
      "sga_expenses": 23569992000,
      "total_assets": 274873511000,
      "total_equity": 186200901000,
      "total_liabilities": 88672610000
    },
    "2023": {
      "capital_stock": 38447091000,
      "cost_of_sales": 4742771000,
      "current_assets": 42060694000,
      "current_liabilities": 53372414000,
      "gross_profit": 1563109000,
      "net_income": -57268722000,
      "net_income_bs": -54326878000,
      "non_current_assets": 212473888000,
      "non_current_liabilities": 37839788000,
      "non_operating_expenses": 90807062000,
      "non_operating_income": 65013787000,
      "operating_profit": -31475447000,
      "revenue": 6305880000,
      "sga_expenses": 33038556000,
      "total_assets": 254534582000,
      "total_equity": 163322380000,
      "total_liabilities": 91212202000
    },
    "2024": {
      "capital_stock": 38447091000,
      "cost_of_sales": 5681141000,
      "current_assets": 36329552000,
      "current_liabilities": 65226918000,
      "gross_profit": -1592904000,
      "net_income": -50349672000,
      "net_income_bs": -51168366000,
      "non_current_assets": 171642503000,
      "non_current_liabilities": 44091396000,
      "non_operating_expenses": 33193045000,
      "non_operating_income": 20177605000,
      "operating_profit": -37334232000,
      "revenue": 4088237000,
      "sga_expenses": 35741329000,
      "total_assets": 207972055000,
      "total_equity": 98653741000,
      "total_liabilities": 109318314000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "생명공학이용 의약품(신규항생제프로젝트,비만치료제,항암제,천식치료제,당뇨치료제) 개발,연구",
  "phone": "02-2107-****",
  "years": [
    2024,
    2023,
    2022
  ]
}